NO169323C - Fremgangsmaate til fremstilling av en steril enhetsdoseform, av 7-(dimetylaminometylen)-amino-9a-metoksymitosan i glass - Google Patents

Fremgangsmaate til fremstilling av en steril enhetsdoseform, av 7-(dimetylaminometylen)-amino-9a-metoksymitosan i glass

Info

Publication number
NO169323C
NO169323C NO860668A NO860668A NO169323C NO 169323 C NO169323 C NO 169323C NO 860668 A NO860668 A NO 860668A NO 860668 A NO860668 A NO 860668A NO 169323 C NO169323 C NO 169323C
Authority
NO
Norway
Prior art keywords
metoxymitosan
dimethylaminomethyl
amino
preparing
procedure
Prior art date
Application number
NO860668A
Other languages
English (en)
Norwegian (no)
Other versions
NO169323B (no
NO860668L (no
Inventor
Murray Arthur Kaplan
Dolatrai M Vyas
Nageswara R Palepu
Chih-Ming J Chen
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO860668L publication Critical patent/NO860668L/no
Publication of NO169323B publication Critical patent/NO169323B/no
Publication of NO169323C publication Critical patent/NO169323C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
NO860668A 1985-02-25 1986-02-24 Fremgangsmaate til fremstilling av en steril enhetsdoseform, av 7-(dimetylaminometylen)-amino-9a-metoksymitosan i glass NO169323C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70524385A 1985-02-25 1985-02-25

Publications (3)

Publication Number Publication Date
NO860668L NO860668L (no) 1986-08-26
NO169323B NO169323B (no) 1992-03-02
NO169323C true NO169323C (no) 1992-06-10

Family

ID=24832630

Family Applications (1)

Application Number Title Priority Date Filing Date
NO860668A NO169323C (no) 1985-02-25 1986-02-24 Fremgangsmaate til fremstilling av en steril enhetsdoseform, av 7-(dimetylaminometylen)-amino-9a-metoksymitosan i glass

Country Status (29)

Country Link
US (1) US4792566A (it)
JP (1) JPS61246125A (it)
KR (1) KR860006267A (it)
CN (1) CN1011289B (it)
AT (1) AT392001B (it)
AU (1) AU593786B2 (it)
BE (1) BE904272A (it)
CA (1) CA1262097A (it)
CH (1) CH670387A5 (it)
DD (1) DD243207A5 (it)
DE (1) DE3605888A1 (it)
DK (1) DK166307C (it)
ES (1) ES8705233A1 (it)
FI (1) FI83038C (it)
FR (1) FR2581870B1 (it)
GB (1) GB2171408B (it)
GR (1) GR860534B (it)
HU (1) HU193850B (it)
IT (1) IT1188708B (it)
LU (1) LU86320A1 (it)
MY (1) MY102923A (it)
NL (1) NL8600455A (it)
NO (1) NO169323C (it)
NZ (1) NZ215122A (it)
OA (1) OA08211A (it)
PT (1) PT82078B (it)
SE (1) SE8600830L (it)
YU (1) YU45304B (it)
ZA (1) ZA86308B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216011A (en) * 1989-09-01 1993-06-01 Bristol-Myers Squibb Co. Stable solutions of mitomycin c
CN101581054B (zh) * 2009-05-27 2012-02-15 安徽万邦高森造纸有限公司 一种涂胶碱性电池隔膜纸的纸浆料及应用该纸浆料制备隔膜纸的制备工艺
ES2771227T3 (es) 2013-10-22 2020-07-06 Medac Ges Fuer Klinische Spezialpraeparate Mbh Procedimiento de preparación de una composición farmacéutica liofilizada que contiene mitomicina C

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660578A (en) * 1957-04-06 1972-05-02 Kyowa Hakko Kogyo Kk Mitomycin c
ZA833967B (en) * 1982-06-04 1984-02-29 Bristol Myers Co Amidines
US4487769A (en) * 1982-06-04 1984-12-11 Bristol-Myers Company Amidines
JPS60255789A (ja) * 1984-06-01 1985-12-17 Kyowa Hakko Kogyo Co Ltd マイトマイシン誘導体，その製造法および抗腫瘍剤
US4639528A (en) * 1985-02-21 1987-01-27 Bristol-Myers Company Crystalline form of 7-(dimethylaminomethylene-amino-9a-methoxymitosane
DE3674043D1 (de) * 1985-04-10 1990-10-18 Kyowa Hakko Kogyo Kk Pharmakologisch aktive mitomycinderivate.

Also Published As

Publication number Publication date
GB2171408A (en) 1986-08-28
YU25986A (en) 1987-12-31
CH670387A5 (it) 1989-06-15
FI860735A (fi) 1986-08-26
IT8619493A0 (it) 1986-02-21
PT82078B (pt) 1988-07-01
YU45304B (en) 1992-05-28
DK166307C (da) 1993-08-23
HUT40327A (en) 1986-12-28
SE8600830D0 (sv) 1986-02-24
FI83038C (fi) 1991-05-27
KR860006267A (ko) 1986-09-09
FI83038B (fi) 1991-02-15
SE8600830L (sv) 1986-08-26
GB8604514D0 (en) 1986-04-03
DE3605888A1 (de) 1986-08-28
CA1262097A (en) 1989-10-03
AU5368486A (en) 1986-08-28
FR2581870A1 (fr) 1986-11-21
CN1011289B (zh) 1991-01-23
MY102923A (en) 1993-03-31
GB2171408B (en) 1988-07-13
AT392001B (de) 1991-01-10
NO169323B (no) 1992-03-02
NZ215122A (en) 1989-06-28
JPS61246125A (ja) 1986-11-01
GR860534B (en) 1986-06-24
DD243207A5 (de) 1987-02-25
DK166307B (da) 1993-04-05
ES552323A0 (es) 1987-05-01
HU193850B (en) 1987-12-28
NO860668L (no) 1986-08-26
DK85486D0 (da) 1986-02-24
FI860735A0 (fi) 1986-02-19
FR2581870B1 (fr) 1989-03-03
ATA49686A (de) 1990-07-15
AU593786B2 (en) 1990-02-22
DK85486A (da) 1986-08-26
LU86320A1 (fr) 1986-09-02
OA08211A (fr) 1987-10-30
US4792566A (en) 1988-12-20
ES8705233A1 (es) 1987-05-01
IT1188708B (it) 1988-01-28
ZA86308B (en) 1986-11-26
NL8600455A (nl) 1986-09-16
BE904272A (fr) 1986-08-25
PT82078A (en) 1986-03-01
CN86100997A (zh) 1986-10-22

Similar Documents

Publication Publication Date Title
DK352686A (da) Steril, farmaceutisk tpa-doseringsenhed og fremgangsmaade til fremstilling deraf, beholdersaet indeholdende tpa og doseringsenhedens anvendelse
NO871408L (no) Forbedringer ved farmasoeytiske akseptable salter.
NO875082D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
FR2593809B1 (fr) Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
FI871294A (fi) Menetelmä lääkeaineina käyttökelpoisten milbemysiinin johdannaisten valmistamiseksi
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
DE3664562D1 (en) Process for the preparation of labdane derivatives, and their pharmaceutical use
NO165545C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye oksadiazolimidazo-benzodiazepinderivater.
ES2061826T3 (es) Un procedimiento de preparacion de derivados n-2,3-butadienil triaminoalcanos.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
BG44709A3 (bg) Метод за получаване на 9-хлор-1,5-бензотиазепинови производни
GR3002266T3 (en) Process for the preparation of single dosage administration forms, and administration forms thus obtained
NO169323C (no) Fremgangsmaate til fremstilling av en steril enhetsdoseform, av 7-(dimetylaminometylen)-amino-9a-metoksymitosan i glass
NO168110C (no) Fremgangsmaate for fremstilling av en steril, ikke betennelses-fremkallende, varmeresistent hyaluronsyrefraksjon
NO864101L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO865139L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperazin-1,4-naftalendion-derivater.
NO168176C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider
FI93725B (fi) Menetelmä optisesti aktiivisten, oikealle kiertävien okso-isoindolinyylijohdannaisten valmistamiseksi
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
DK613486D0 (da) 1-h-pyrido-(3,2-b)(1,4)-thiaziner, fremgangsmaade til deres fremstilling og deres anvendelse i laegemidler
DE3877747D1 (de) Glasartige matrize zur verabreichung von heilmitteln.